Home › Compare › CIIHY vs ABBV
CIIHY yields 2.85% · ABBV yields 3.12%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, CIIHY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CIIHY + ABBV for your $10,000?
CITIC Securities Company Limited provides various financial products and services in Mainland China and internationally. It operates through Investment Banking, Brokerage, Trading, Asset Management, and Others segments. The company offers investment banking services, including equity and debt financing, as well as fundraising and financial advisory services to a range of enterprises and other institutional clients. It is also involved in the broking of securities and futures; distribution of financial products; and trading and market-making of equity products, fixed income products and derivatives, foreign exchange, margin financing and securities lending, alternative investment, and commodities business. In addition, the company offers asset management services, such as collective asset management, specialized asset management, separately managed account, fund management, and other investment accounts management; private equity investment and other services; and custody and research services. Further, it provides institutional brokerage, investment advisory and management, investment consultancy, fiduciary management, fund, real estate, business training, and financial products and securities investment services. Additionally, the company offers finance outsourcing, bond issuance, offshore portfolio hedge and investment fund, fund distribution, leveraged foreign exchange and other transactions, investment with self-owned capital, cash transactions, property management and leasing, and other services. It also engages in information technology development, technical consulting, research and development of financial products, portfolio design, and consulting activities. CITIC Securities Company Limited was incorporated in 1995 and is based in Beijing, the People's Republic of China.
Full CIIHY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.